BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Pharmacyclics, Inc. 

995 East Arques Avenue

Sunnyvale  California  94086  U.S.A.
Phone: 408-774-0330 Fax: 408-774-0340


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Market Analysis: Pharmacyclics (PCYC) Sale Good Idea if Buyer Understands Imbruvica Potential, Says Analyst 2/26/2015 3:14:26 PM
Bay Area's Pharmacyclics (PCYC) Mulls Possible $18 Billion Sale; Johnson & Johnson (JNJ),Novartis AG (NVS) Interested 2/26/2015 5:53:26 AM
Pharmacyclics, Inc. (PCYC) Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Business Updates 2/18/2015 2:35:11 PM
Pharmacyclics, Inc. (PCYC) Release: IMBRUVICA (ibrutinib) Treatment Shows Efficacy And Tolerability In Heavily Treated Chronic Lymphocytic Leukemia Patients Following Allogeneic Stem Cell Transplant 2/17/2015 8:50:05 AM
Pharmacyclics, Inc. (PCYC) Announces Conference Call To Discuss Fourth Quarter And Full Year 2014 Financial Results 2/12/2015 10:35:03 AM
Pharmacyclics, Inc. (PCYC) Announces Preliminary 2014 U.S. Net Product Revenue Results And 2015 U.S. Net Product Revenue Outlook 1/13/2015 9:50:40 AM
Pharmacyclics, Inc. (PCYC) Release: IMBRUVICA® (ibrutinib) Data Demonstrates Efficacy In Previously Untreated And Relapsed/Refractory High-Risk Chronic Lymphocytic Leukemia Patients 1/5/2015 7:29:12 AM
Pharmacyclics, Inc. (PCYC) Announces Update On IMBRUVICA® (Ibrutinib) Waldenstrom's Macroglobulinemia (WM) Submission 12/22/2014 8:19:16 AM
Pharmacyclics, Inc. (PCYC) Named 2014 Outstanding Company By BayBio (Bay Area Bioscience Association) 12/12/2014 8:23:38 AM
Pharmacyclics, Inc. (PCYC) Release: Longer Follow-Up IMBRUVICA (ibrutinib) Treatment Demonstrates Sustained Efficacy In Patients With Difficult-To-Treat Chronic Lymphocytic Leukemia (CLL) 12/9/2014 8:46:15 AM
12345678910...